Biological variation estimates of prothrombin time, activated partial thromboplastin time, and fibrinogen in 28 healthy individuals
- 20 August 2018
- journal article
- research article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 40 (6) , 721-725
Abstract
Background: Although tests of global hemostasis prothrombin time (PT) and activated partial thromboplastin time (aPTT) should not be used for prediction of bleeding risk, these tests are often used by many clinicians in daily practice particularly as a preoperative screening test. Robust biological variation (BV) data are needed for safe clinical applications of these tests. In this study, a stringent protocol was followed to estimate the BV's for PT, aPTT, and fibrinogen levels.Methods: Weekly blood samples were obtained from 28 healthy individuals (18 females, 10 males) during 10 weeks study period. All measurements were performed with Stago STA‐R coagulation analyzer. Prior to coefficient of variation (CV)‐analysis of variance (ANOVA), the data were assessed for normality, trends, outliers, and variance homogeneity. Sex‐stratified within‐individual (CVI) and between‐individual (CVG) BV estimates were determined for PT, aPTT, and fibrinogen tests.Results: No difference was found between male and female estimates of BV. The observed CVI and CVG estimates were found to be lower than those previously published. Only for fibrinogen, CVI was higher than CVG.Conclusion: Following a meticulous protocol, our study results provide up‐to‐date and more stringent BV estimates of global hemostasis tests.Keywords
This publication has 15 references indexed in Scilit:
- Sample collections from healthy volunteers for biological variation estimates’ update: a new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory MedicineClinical Chemistry and Laboratory Medicine (CCLM), 2016
- Biological and Analytical Variations of 16 Parameters Related to Coagulation Screening Tests and the Activity of Coagulation FactorsSeminars in Thrombosis and Hemostasis, 2015
- A checklist for critical appraisal of studies of biological variationClinical Chemistry and Laboratory Medicine (CCLM), 2015
- Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory MedicineClinical Chemistry and Laboratory Medicine (CCLM), 2015
- Biological Variation in Tests of HemostasisSeminars in Thrombosis and Hemostasis, 2009
- Biological Variation in Tests of HemostasisSeminars in Thrombosis and Hemostasis, 2008
- The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variationScandinavian Journal of Clinical and Laboratory Investigation, 2004
- The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipidsAtherosclerosis, 1992
- An analysis of variance test for normality (complete samples)Biometrika, 1965
- Processing Data for OutliersBiometrics, 1953